Intracavernous Stem Cell Transplantation in Erectile Dysfunction: Modification of Adhesive Properties of Stem Cells Increases Their Ability to Restore Contractile and Phosphatase Activity of Cavernous Tissue Damaged by Hyperglycemia
##plugins.themes.bootstrap3.article.main##
Abstract
A comparative study of the effect on the contractile and phosphate activity of the cavernous tissue of four intracavernous injections (ICI) (1×106 cells once a week) of native stem cells (SC) and cells, with SYT1/SYT2 molecules, integrated into the cell membrane (SC-m-SYT1/SYT2), was performed in two groups (n=10; 1:1) of sexually mature Wistar rats weighing 160-180 gwith induced hyperglycemia (>8 mmol/l). It was found that, at the end of the ICI in the group of animals receiving SC-m-SYT1/SYT2, the median amplitude of contractions was 1.6 times greater (P<0.05, Wilcoxon’s test), and the intensity mediants for ATPase and LF, respectively, 2 and 1 points greater than in the group where native SCs were introduced (P<0.05, Wilcoxon’s test). ICI of native and modified SC did not affect the level of glycemia. Modification of the adhesive properties of SC by SYT1/SYT2 molecules increases their ability to restore contractile and phosphatase activity of cavernous tissue damaged by hyperglycemia. Further research is needed on the processes of homing and differentiation of SC, modified with SYT1/SYT2 molecules, in intact and pathologically altered cavernous tissue in vitro and in vivo.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Capogrosso P., Colicchia M, Ventimiglia E, Castagna G, Clementi MC, Suardi N, Castiglione F, Briganti A, Cantiello F, Damiano R, Montorsi F, Salonia A. One patient out of four with newly diagnosed erectile dysfunction is a young man-worrisome picture from the everyday clinical practice //J Sex Med. 2013 Jul;10(7):1833–41. https://doi.org/10.1111/jsm.12179
Emanu J.C., Avildsen I.K., Nelson C.J. Erectile dysfunction after radical prostatectomy: prevalence, medical treatments, and psychosocial Interventions // Curr Opin Support Palliat Care. 2016 Mar;10(1):102–107. https://doi.org/10.1097/SPC.0000000000000195
Mourikis I., Antoniou M., Matsouka E., Vousoura E., Tzavara C., Chrysa Ekizoglou, Papadimitriou G.N., Vaidakis N., Zervas I.M. Anxiety and depression among Greek men with primary erectile dysfunction and premature ejaculation // Ann Gen Psychiatry. 2015;14:34. https://dx.doi.org/10.1186%2Fs12991-015-0074-y
Hatzimouratidis K., Hatzichristou D. Phosphodiesterase type 5 inhibitors: unmet needs // Curr. Pharm. Des. 2009;15(30):3476–85. https://doi.org/10.2174/138161209789207042
Jiann B.P., Yu C.C., Su C.C., Tsai J.Y. Compliance of sildenafil treatment for erectile dysfunction and factors affecting it // Int J Impot Res. 2006 Mar-Apr;18(2):146–9. https://doi.org/10.1038/sj.ijir.3901379
Kwon E.B., Lee J.Y., Piao S., Kim I.G., Ra J.C., Lee J.Y. Comparison of human muscle-derived stem cells and human adipose-derived stem cells in neurogenic trans-differentiation. – Korean J Urol. 2011. – 52 (12). – P. 852–857. https://dx.doi.org/10.4111%2Fkju.2011.52.12.852
Lin G., Banie L., Ning H., Bella A.J., Lin C.S., Lue T.F. Potential of adiposederived stem cells for treatment of erectile dysfunction // J. Sex Med. – 2009. – 6 Suppl 3:320–327. https://dx.doi.org/10.1111%2Fj.1743-6109.2008.01190.x
Ning H., Liu G., Lin G., Yang R., Lue T.F., Lin C.S. Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells // J. Sex. Med. – 2009. – 6 (4). – P. 967–979. https://doi.org/10.1111/j.1743-6109.2008.01172.x
Gholami S.S., Rogers R., Chang J., Ho H.C., Grazziottin T., Lin C.S., Lue T.F. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia // J. Urol. – 2003;169(4). – P. 1577–1581. https://doi.org/10.1097/01.ju.0000055120.73261.76
Hristov M., Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance // J Cell Mol Med 2004;8:498–508. https://doi.org/10.1111/j.1582-4934.2004.tb00474.x
Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease // Circ Res 2001;89:E1–7. https://doi.org/10.1161/hh1301.093953
Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE. Marrow-derived stroll cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms // Circ Res 2004;94:678–685. https://doi.org/10.1161/01.RES.0000118601.37875.AC
Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, Kloner RA. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 2005;112:214–223. https://doi.org/10.1161/CIRCULATIONAHA.104.527937
Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhauser M, Werner C. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004;22:377–384. https://doi.org/10.1634/stemcells.22-3-377
Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279–4295. https://doi.org/10.1091/mbc.e02-02-0105
De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, Dragoo JL, Ashjian P, Thomas // J Am Coll Cardiol. – 2005. – 45:982–988.
Горпинченко І.І., Ситенко А.М., Бухтіарова Т.А., Ядловський О.Є., Матвієнко А.В., Попандопуло А.Г., Кавеліна А.С. Вплив інтракавернозних ін’єкцій кістковомозкових мезенхімальних стовбурових клітин на морфологію та фосфатазну активність печеристої тканини щурів-самців із стретозотоциніндукованим цукровим діабетом // Здоровье мужчины, № 4 (47), 2013. – С. 142–145.
Пат. № 98906 UA, МПК С12Q 1/42, G01N 33/50 (2006.01). Спосіб оцінки стану ендотелію печеристої тканини статевого члена /Горпинченко І.І., Ситенко А.М., Ядловський О.Є., Матвієнко А.В. (UA); ДУ «ІУНАМНУ», ДУ «ІФТНАМНУ» (UA); № u201412923, 03.12.2014; Опуб. 12.05.2015, Бюл. № 9. Full text